May 26, Re: IVIG Administration Codes, RAC Audits
|
|
- Felicity Eaton
- 6 years ago
- Views:
Transcription
1 May 26, 2011 Re: IVIG Administration Codes, RAC Audits Arnold Balanoff, MD Chief Medical Officer Office of the Regional Administrator 601 E. 12th Street, Suite 235 Kansas City, MO In order to provide clarity to providers, reduce cost to CMS and increase patient access to IVIG, CMS should publish a notice that chemotherapeutic administration codes for IVIG should be allowed, and the current RAC audits regarding the use of chemotherapy admin codes with IVIG should be dismissed. Beginning in November 2010, the NICA received notice from our partners that certain Medicare Contractors, were denying and/or down coding high level chemotherapy administration codes on IVIG (Intravenous Immune globulin) claims to lower level therapeutic administration codes. In May 2011, certain Recovery Audit Contractors (RACs) such as Connolly Healthcare began conducting audits in attempts to recover suspected overpayments on certain providers who billed the chemotherapeutic code (complex chemo admin codes) rather than the therapeutic code when administering IVIG. Chemotherapeutic Codes (IVIG administration codes being denied or down coded): Chemotherapy and Complex drugs; Biologicals: Intravenous Infusion up to one hour Chemotherapy and Complex drugs; Biologicals: Intravenous Infusion each additional hour Therapeutic Administration Codes: Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour History: The allowed use of the chemotherapy administration codes for non chemotherapeutic medications is common place among all payers, including CMS and its Medicare Contractors. For intravenous therapies that are deemed complex, including some specialty biological and monoclonal antibody drugs, contractors have allowed providers to bill the higher level chemotherapy administration codes. Many MACs have published specific instructions regarding medications that may be billed with complexchemo admin codes. To view a specific example, please see the Trailblazer notice titled, Chemotherapy Administration Coding issued on July 21, The notice specifically outlines many nonchemotherapeutic drugs that may be billed with complex chemo admin codes. The notice specifically states that the list of drugs that may be billed with complex chemo admin codes is not intended to be complete, and it allows complex chemo admin codes to be billed when medications require physician work or clinical staff monitoring well beyond that of therapeutic drug agents (CPT codes ).
2 A copy of the notice can be found at the following link: Immediate Dismissal of RAC Audits: The current RAC audits should be dismissed based on the fact that no policy prohibiting billing the complex chemo admin code for IVIG or any other complex intravenous medication is readily ascertainable. After speaking with our partners and researching this issue thoroughly, we have found no evidence of a CMS, local Medicare contractor (MAC), or any other regulating body policy stating that IVIG could not or should not be billed with complex chemo admin codes ( ). Our research did find an Office of the Inspector General (OIG) report dated June 2009, titled Chemotherapy Administration: Payment and Policy that states in their findings, Carriers have implemented inconsistent chemotherapy administration coding polices and review procedures" The same OIG report recommends that CMS: Establish a process to determine which specific drugs qualify for the chemotherapy administration rate. Because (i) no policy prohibiting billing complex chemo admin codes with IVIG is available and (ii) the OIG Report s recommendation, the RAC audits should be dismissed. IVIG warrants coverage using chemotherapeutic administration code: IVIG at least warrants the same administration coverage as other monoclonal class drugs such as Remicade, Orencia, and Rituxan due to the increased patient monitoring and administration burdens associated with administering IVIG (see Trailblazer LCD below). Clinically, it is well understood that that IVIG is at least as complex as the chemotherapeutic and non chemotherapeutic medications currently covered under the complex chemo admin codes. (Please see attached chart titled Medication Comparison ). Therefore, the administration of IVIG should be paid at a higher level than the administration of Ceftriaxone (Rocephin), Cipro, and other non complex therapies. Trailblazer Health s LCD (local coverage determination) for IVIG acknowledges that IVIG is clinically difficult to administer: Sensitivity to these (IVIG) reactions is usually related to the infusion rate. Caution should be exercised in the administration of intravenous immune globulin; reactions may cause a rapid fall in blood pressure and clinical anaphylaxis.
3 Solution: Increase Patient Access and reduce CMS costs: The issue of clarifying appropriate administration codes for specialty medications is a core objective of the NICA. We believe it is in the favor of all parties to establish a set criterion for providers that define all specialty injectable/infusible medications and their appropriate administration codes. Providers who remain uncertain about CMS or Medicare contractor policies for administration codes are more likely to not offer these medications in their practice out of concern for possible future auditing and medical review. This uncertainty means more patients will have to receive these specialty medications at a nonpreferred, high cost facility such as a hospital where costs for the patient and payer can easily double and increase by as much as 100%. It is proven that infusion therapy administered in a provider s office is significantly less expensive than the hospital. Conclusion and Recommendations: The NICA is asking CMS Medical Directors and appropriate staff to consider the benefits of the discussion on this topic. Clarity on this issue will insure that chronically ill patients can continue to receive their treatments in a lower cost, non hospital setting. Accordingly, the NICA is asking CMS to: Publish a notice clarifying the allowed use of the higher level complex chemo codes when administering biologic, specialty drugs like IVIG, and Remove the RAC audit approved issue Chemotherapy Administration Codes and rescind the corresponding RAC audits on the issue If you have comments on this letter, you may them to bryan.johnson@infusioncenter.net Thank you, Bryan Johnson, President National Infusion Center Association Enclosures: 1. Administration Code Comparison Chart 2. OIG Report, Medicare Part B Chemotherapy Administration Payment and Policy, June Trailblazer Chemotherapy Administration Code Policy dated July 21,
4 Administration Code Comparison Chart Current Covered (96413, 96415) Medications vs. IVIG ADMINISTRATION REQUIREMENTS Direct Physician/Nurse Supervision Specialized Preparation Infusion Pump Recommended Pre Treatment Screening Dosage Adjustments at Time of Treatment (weight based dosing) Infusion Rate Change Required During Treatment PATIENT MONITORING Frequent Vitals During Infusion Frequent Assessments During Treatment Post Infusion Instruction Recommended ADVERSE EVENTS PROFILE Higher Incidence of Infusion related reactions Higher Risk of Infusion Anaphylaxis Increases/Decreases in Blood Pressure Avg. Treatment Inventory Cost (Per Day) MEDICATION Remicade X X X X X X X X X X X X $2,800-4,000 Actemra X X X X X X X X X $1,000-1,500 Rituximab X X X X X X X X X X X $3,000-7,500 Tysabri X X X X X X X X X X X $2,500 Xolair X X X X X X X X $600-2,400 Orencia X X X X X X X $600-1,200 Avg. Therapeutic Drug * * * * $5-150 IVIG (all brands) X X* X X X X X X X X X X $2,500-7,500 From Trailblazer Health Enterprises LCD L26774: Sensitivity to these reactions is usually related to the infusion rate. Caution should be exercised in the administration of intravenous immune globulin; reactions may cause a rapid fall in blood pressure and clinical anaphylaxis. *Some specialized therapeutic medications will require these conditions **IVIG preparation varies from Lyophilized & Liquid products/brands
5 Notices Tools TrailBlazerHealth.com - Chemotherapy Administration Coding Page 1 of 2 4/11/2011 HOW DO I? CALENDAR OF EVENTS NOTICES LISTSERVS FAQS SELF-SERVICE TOOLS CONTACT US Welcome. LOGIN REGISTER Search Quick Links FEE SCHEDULES FORMS LOCAL COVERAGE DETERMINATIONS EVALUATION AND MANAGEMENT APPEALS AUDIT & REIMBURSEMENT BENEFICIARY CERT CLAIMS CUSTOMER SERVICE EDUCATION EDI FACILITY TYPES MSP PAYMENT POLICIES PROVIDER ENROLLMENT PUBLICATIONS QUALITY INITIATIVES SPECIALTY SERVICES Printable View RSS Feed Site Tutorial Download Adobe Reader TrailBlazer Sites Medicare Home Page Corporate We Are Listening! Send us your Web site feedback. Visit the Program Safeguard Contractor for the J4 MAC areas. Notices Medicare Home Page Notices CMS and TrailBlazer Are Official Sources for Medicare Information All TrailBlazer Part A and Part B notices will be posted to this site. Users are able to view the latest information from TrailBlazer and CMS, such as CR or JSM instructions, or easily retrieve the most up-to-date information without searching the entire site. The CMS mandated notices will include a link to the CMS Web site where providers may view the transmittals in their entirety. For your convenience, notices are listed in date order with the most current being shown first. This page is updated daily. Search other Notices Chemotherapy Administration Coding (7/21/2010) TrailBlazer s Medical Review staff recently performed a number of audits on several drugs and associated drug administration codes. Findings of the audit indicate the need for review of the proper use of chemotherapy administration CPT codes The full instructions for the use of these codes are located in two separate documents. The chemotherapy administration CPT codes ( ): Are used to report the administration of certain non-radionuclide drugs when the infusion requires physician work or clinical staff monitoring well beyond that of therapeutic drug agents (CPT codes ). Apply to parenteral administration of non-radionuclide antineoplastic drugs, antineoplastic agents provided for the treatment of non-cancer diagnoses (e.g., cyclophosphamide for autoimmune conditions), substances such as monoclonal antibody agents and other biologic response modifiers. Drugs commonly falling in the category of monoclonal antibodies include infliximab, rituximab, alemtuzumb, gemtuzumab and trastuzumab. Drugs commonly falling in the category of hormonal antineoplastics include leuprolide acetate and goserelin acetate. The drugs listed above are not intended to be a complete list of drugs that may be administered using the chemotherapy administration codes. The chemotherapy administration CPT codes ( ) may not be used to report administration of: Substances used as diagnostic agents such as radio-opaque dyes. Therapeutic radionuclides (use CPT codes 79101, or 79999). Anti-anemia drugs. Anti-emetic drugs. Hydration fluids. Drugs that appear on the usually self-administered drug exclusion list. If performed to facilitate the chemotherapy infusion or injection, the following services and items are included in the payment for CPT codes and are not separately billable/payable: Use of local anesthesia. Establishing IV access. Access to indwelling IV, subcutaneous catheter or port. Flush at conclusion of infusion. Standard tubing, syringes and supplies. Preparation of chemotherapy agent(s). If a significant, separately identifiable Evaluation and Management (E/M) service is performed, the appropriate E/M code should be reported utilizing modifier 25 in addition to the chemotherapy code. For an E/M service provided on the same day, a different diagnosis is not required. Additional detailed information is available in the preamble of the CPT codebook and in the Internet-Only Manual (IOM) Pub , Medicare Claims Processing Manual, Chapter 12, Section 30.5.D. (Reference: From the Desk of the Medical Director) This content pertains to... Programs: Part A,Part B Topics: Policies, Specialty Services Subtopics: Chemotherapy, Contractor Medical Directors, Drugs and Biologicals AMA CPT / ADA CDT Copyright Statement CPT codes, descriptions and other data only are copyright 2010 American Medical Association (or such other date of publication of CPT). All Rights Reserved. Applicable FARS/DFARS Clauses Apply. Current Dental Terminology, (CDT) (including procedure codes, nomenclature, descriptors and other data contained therein) is copyright by the American Dental Association American Dental Association. All rights reserved. Applicable FARS/DFARS apply.
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
Eliminating Infusion Confusion
Eliminating Infusion Confusion (Drug Administrations in Non-facility Settings) Maryann C. Palmeter, CPC, CENTC Agenda Review of CPT codes (added in 2009) Documentation principles Key definitions What s
More informationREPORT OF THE COUNCIL ON MEDICAL SERVICE. Parity of Payment for Administering Biologic Medications (Resolution 218-I-14)
REPORT OF THE COUNCIL ON MEDICAL SERVICE CMS Report -I- Subject: Presented by: Referred to: Parity of Payment for Administering Biologic Medications (Resolution -I-) Robert E. Hertzka, MD, Chair Reference
More informationCMS , Medicare Benefit Policy Manual, Chapter 15- Section 50 - Drugs and Biologicals:
Billing and Coding Guidelines for Drugs and Biologics (Non-chemotherapy) L 34741 Medicare Excerpts: CMS 100-02, Medicare Benefit Policy Manual, Chapter 15- Section 50 - Drugs and Biologicals: 50.2 - Determining
More information10/2/2014. Documentation and Billing Compliance for High-Cost Drugs and Devices. The Problem
Documentation and Billing Compliance for High-Cost Drugs and Devices Ferah Syed, MD Director of Coding Services McBee Associates, Inc. Sandy Piersol Compliance Officer McBee Associates, Inc. Copyright
More informationDepartment of Health & Human Services (DHHS) Pub Medicare Claims Processing Centers for Medicare &
CMS Manual System Department of Health & Human Services (DHHS) Pub. 100-04 Medicare Claims Processing Centers for Medicare & Medicaid Services (CMS) Transmittal 557 Date: MAY 6, 2005 CHAGE REQUEST 3848
More informationCoding Essentials for Infusion and Injection Therapy Services 2018
Coding Essentials for Infusion and Injection Therapy Services 2018 A guide for outpatient injections, non-chemotherapy and chemotherapy administration services Prepared and Published By: MedLearn Publishing
More informationUNCLASSIFIED J-CODE CODING AND BILLING US/ULT-PNH/0002
UNCLASSIFIED J-CODE CODING AND BILLING UNCLASSIFIED/MISCELLANEOUS CODES Used when no existing national code adequately describes the item or service being billed Allows suppliers to begin billing immediately
More informationCalendar Year 2018 Medicare Physician Fee Schedule Proposed Rule
Calendar Year 2018 Medicare Physician Fee Schedule Proposed Rule August 2017 This document is presented for informational purposes only and is not intended to provide reimbursement or legal advice. Laws,
More informationMedicare Boot Camp Critical Access Hospital and Rural Health Clinic Version
Medicare Boot Camp Critical Access Hospital and Rural Health Clinic Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Master Medicare rules for critical access
More informationMedicare Boot Camp Critical Access Hospital and Rural Health Clinic Version
Medicare Boot Camp Critical Access Hospital and Rural Health Clinic Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Master Medicare rules for critical access
More informationMedicare Boot Camp Critical Access Hospital and Rural Health Clinic Version
Medicare Boot Camp Critical Access Hospital and Rural Health Clinic Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Master Medicare rules for critical access
More informationMedicare Boot Camp Critical Access Hospital Version
Medicare Boot Camp Critical Access Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Master Medicare rules for critical access hospitals Medicare
More informationMedicare Boot Camp Critical Access Hospital Version
Medicare Boot Camp Critical Access Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Master Medicare rules for critical access hospitals Medicare
More informationMedicare Boot Camp Critical Access Hospital Version
Medicare Boot Camp Critical Access Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Master Medicare rules for critical access hospitals Medicare
More informationLaboratory Tests Chronic Renal Deficiency (CRD) Patients (NCD )
Policy Number 190.10 Approved By UnitedHealthcare Medicare Reimbursement Policy Committee Current Approval Date 03/26/2014 IMPORTANT NOTE ABOUT THIS REIMBURSEMENT POLICY This policy is applicable to UnitedHealthcare
More informationRe: Draft Local Coverage Determination for Gonadotropin-Releasing Hormone Analogs (Revised DL22520 and DL22568)
Bruce Quinn, MD Contractor Medical Director National Heritage Insurance Company (NHIC) 1055 West 7th Street, Suite 500 Los Angeles, CA 90017 Re: Draft Local Coverage Determination for Gonadotropin-Releasing
More informationMedicare Boot Camp Rural Health Clinic Version
Medicare Boot Camp Rural Health Clinic Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Medicare Boot Camp Rural Health Clinic Version is a one-day intensive
More informationMedicare Boot Camp Rural Health Clinic Version
Medicare Boot Camp Rural Health Clinic Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Medicare Boot Camp Rural Health Clinic Version is a one-day intensive
More informationMedicare Boot Camp Rural Health Clinic Version
Medicare Boot Camp Rural Health Clinic Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Medicare Boot Camp Rural Health Clinic Version is a one-day intensive
More informationBilling and Coding Guide. Physician Office
Billing and Coding Guide Physician Office Coverage, coding, and payment in the physician office ONPATTRO (patisiran) received US Food and Drug Administration (FDA) approval on 10 Aug 2018, and is indicated
More informationCpt code for ivig infusion 2017
Cerca Cpt code for ivig infusion 2017 May 26, 2017. The provider bills the per diem charge for five days of IVIG therapy on. Nursing services (CPT codes 99601 and 99602) are covered and do. patients in
More informationPHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)
PHYSICIAN OFFICE BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable
More informationChargemaster Compliance & Revenue Capture. Scott Treida, MT (ASCP), CPC Director
Chargemaster Compliance & Revenue Capture Scott Treida, MT (ASCP), CPC Director 317-713-7950 streida@blueandco.com Disclaimer This presentation has been designed to provide illustrative information with
More informationHow To Respond To An Audit. Guillermo Beades, Esq.
How To Respond To An Audit Guillermo Beades, Esq. The Audit Process The Audit Process Risk Factors What factors put practices at increased risk for an audit? Disgruntled employees Dissatisfied patients
More informationChargemaster Compliance & Revenue Capture
Chargemaster Compliance & Revenue Capture HFMA Arkansas Chapter Summer Conference August 23, 2018 Scott Treida, MT (ASCP), CPC Blue & Co., LLC Director Charge Capture & The Chargemaster Order Completion
More informationPhysician Office Billing & Payment Guide
Physician Office Billing & Payment Guide Dermal Regeneration Matrix Dermal Repair Scaffold Ag Antimicrobial Dermal Repair Scaffold Physician Office Billing & Payment Guide Billing and Medicare Payment
More informationMedicare Review Entities 101
Medicare Review Entities 101 Presented by: Beth Nordby, RN Josephine Hunt-Pfautz, BA DISCLAIMER This information release is the property of Noridian Healthcare Solutions, LLC. It may be freely distributed
More informationG8876 DOCUMENTATION OF REASON(S) FOR NOT PERFORMING MINIMALLY INVASIVE BIOPSY TO DIAGNOSE BREAST CANCER PREOPERATIVELY (E.G
G8876 DOCUMENTATION OF REASON(S) FOR NOT PERFORMING MINIMALLY INVASIVE BIOPSY TO DIAGNOSE BREAST CANCER PREOPERATIVELY (E.G., LESION TOO CLOSE TO SKIN, IMPLANT, CHEST WALL, ETC., LESION COULD NOT BE ADEQUATELY
More informationImmunizations, injections and infusions (including triggerpoint injections), skin substitutes, and provider-administered pharmaceuticals.
ACTION: Final DATE: 10/12/2017 3:11 PM 5160-4-12 Immunizations, injections and infusions (including triggerpoint injections), skin substitutes, and provider-administered pharmaceuticals. (A) General provisions.
More informationHEPATIC ARTERIAL INFUSION SYSTEMS. All Medicare payment rates are current as of the time of printing.
CODING SHEETS HEPATIC ARTERIAL INFUSION SYSTEMS Effective January 2011 CODMAN 3000 NEUROMODULATION AND ONCOLOGY REIMBURSEMENT HOTLINE Phone: 800-609-1108 Email: codmanpump@aol.com Fax: 303-703-1572 CODMAN
More informationCristine M. Miller, CMPE, CCP, CHC November 8, An Independent Member of Baker Tilly International
Cristine M. Miller, CMPE, CCP, CHC November 8, 2011 Cristine Miller Certified Medical Practice Executive (CMPE) Certified Coding Professional (CCP) Certified in Healthcare Compliance (CHC) 24 years experience
More informationMarilyn Tavenner Acting Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD
Marilyn Tavenner Acting Administrator Centers for Medicare & Medicaid Services 7500 Security Boulevard Baltimore, MD 21244-1850 RE: Calendar Year 2013 Centers for Medicare and Medicaid Services (CMS) New
More informationMedical Pharmacy Trend Report: Managing the Trends and Complexity of Provider- Administered Drugs
Medical Pharmacy Trend Report: Managing the Trends and Complexity of Provider- Administered Drugs Thursday, March 10, 2016 1:00 2:30 EST 12:00 1:30 CST 11:00 12:30 MST 10:00 11:30 PST Casandra Stockman,
More informationCOVERAGE ELIGIBILITY OF SERVICES ASSOCIATED WITH A CLINICAL TRIAL
Coverage for services, procedures, medical devices and drugs are dependent upon benefit eligibility as outlined in the member's specific benefit plan. This Medical Coverage Guideline must be read in its
More informationProvider Audit Contractors Medicare Administrative Contractors - Cost Report Audit & Reimbursement
Provider Audit Contractors Medicare Administrative Contractors - Cost Report Audit & Reimbursement AHLA Institute on Medicare and Medicaid Payment Issues March 26, 2014 Mark Korpela CMS, Office of Financial
More informationMedicare Program Integrity Manual
Medicare Program Integrity Manual Chapter 2 Data Analysis Transmittals for Chapter 2 Table of Contents (Rev. 658, 06-22-16) 2.1 - Identifying Potential Errors - Introduction 2.2. - Data Analysis 2.3 -
More informationImproving Revenue Integrity Through Effective Coding and Denials Management
Improving Revenue Integrity Through Effective Coding and Denials Management June 1, 2018 HFMA Massachusetts/Rhode Island Chapter Christy Matheson, RHIA, CCS Medical Record Associates, LLC OBJECTIVES: Understand
More informationMedicare Boot Camp - Hospital Version
Medicare Boot Camp - Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Gain insight into the CMS initiatives affecting your revenue in 2019 by joining
More informationMedicare Boot Camp - Hospital Version
Medicare Boot Camp - Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Gain insight into the CMS initiatives affecting your revenue in 2019 by joining
More informationMedicare Boot Camp - Hospital Version
Medicare Boot Camp - Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Gain insight into the CMS initiatives affecting your revenue in 2019 by joining
More informationMedicare Boot Camp - Hospital Version
Medicare Boot Camp - Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Gain insight into the CMS initiatives affecting your revenue in 2019 by joining
More informationMedicare Boot Camp - Hospital Version
Medicare Boot Camp - Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Gain insight into the CMS initiatives affecting your revenue in 2019 by joining
More informationHOSPITAL OUTPATIENT BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec)
HOSPITAL OUTPATIENT BILLING INFORMATION SHEET FOR IMLYGIC (talimogene laherparepvec) INDICATION IMLYGIC is a genetically modified oncolytic viral therapy indicated for the local treatment of unresectable
More informationClinical Policy: Sargramostim (Leukine) Reference Number: CP.CPA.262 Effective Date: Last Review Date: Line of Business: Commercial
Clinical Policy: (Leukine) Reference Number: CP.CPA.262 Effective Date: 11.16.16 Last Review Date: 08.18 Line of Business: Commercial Coding Implications Revision Log See Important Reminder at the end
More informationStrategies to Reduce Pharmacy Claims Denials
Strategies to Reduce Pharmacy Claims Denials Pharmacy OneSource Webinar Ellen Fan, R.Ph. Clinical Financial Analysis Pharmacist Corporate Pharmacy December 16, 2010 Objectives Describe steps taken to create
More informationMedicare Boot Camp - Hospital Version
Medicare Boot Camp - Hospital Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Gain insight into the CMS initiatives affecting your revenue in 2019 by join
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Pegfilgrastim (Neulasta), Pegfilgrastim-jmdb (Fulphila) Reference Number: CP.PHAR.296 Effective Date: 12.01.16 Last Review Date: 02.19 Line of Business: Commercial, HIM*, Medicaid Coding
More informationAdministrator Verma. September 11, 2017 Page 1 of 11. September 11, 2017
Page 1 of 11 Seema Verma Administrator Centers for Medicare and Medicaid Services Department of Health and Human Services Room 445-G Hubert H. Humphrey Building 200 Independence Ave., SW Washington, DC
More informationA New Era of Clinical Diagnostics: How the Business Model is Changing.
A New Era of Clinical Diagnostics: How the Business Model is Changing. Nancy J Kelley, President and CEO of Nancy J Kelley & Associates Remarks to BTIG Emerging Technologies in Healthcare Diagnostics September
More informationMedicare and Medicaid Audits
Medicare and Medicaid Audits Ready or Not Here They Come Presented by: www.thehealthlawfirm.com As Presented to Medical Office Resources of Florida (MOROF) Howard Johnson Plaza Altamonte Springs, Florida
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Policy: Erythropoiesis Stimulating Agents (ESAs) Reference Number: TCHP.PHAR.1813 Effective Date: 07.01.18 Last Review Date: 04.13.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder
More informationThe Art & Science of Designing a Physician Practice Audit: Unique Techniques
The Art & Science of Designing a Physician Practice Audit: Unique Techniques Lori Laubach, Health Care Partner 1 The material appearing in this presentation is for informational purposes only and is not
More informationClinical Policy: Filgrastim, Filgrastim-sndz, Tbo-filgrastim Reference Number: CP.PHAR.297
Clinical Policy: Reference Number: CP.PHAR.297 Effective Date: 12/16 Last Review Date: 10/16 Coding Implications Revision Log See Important Reminder at the end of this policy for important regulatory and
More information1/17/2014. Objectives. What is a chart audit? Audits are like mountain biking you must have the right tools to have a successful ride!
Audits are like mountain biking you must have the right tools to have a successful ride! 1 Objectives 1. Understand benefits of a chart audit 2. Gain understanding of types of audits 3. Learn of effective
More informationWHAT DO YOUR PROVIDERS DO?
Presented by Angela Brown, CHCA, CHC, CCS-P, PCS Deputy HSC Compliance Officer Director of Compliance Education Interim Audit Manager University of Louisville Health Sciences Center 1 Learning Points Why
More informationMedicare Program Integrity Manual
Medicare Program Integrity Manual Chapter 2 Data Analysis Transmittals for Chapter 2 Table of Contents (Rev. 313, 11-20-09) 2.1 - Identifying Potential Errors - Introduction 2.2. - Data Analysis 2.3 -
More informationReview of Medicare Part B Avastin and Lucentis Treatments for Age-Related Macular Degeneration (A )
DEPARTMENT OF HEALTH & HUMAN SERVICES Office of Inspector General Washington, D.C. 20201 September 6, 2011 TO: Donald M. Berwick, M.D. Administrator Centers for Medicare & Medicaid Services FROM: /Daniel
More informationCharge Capture: What You Don t Know IS Killing You!
Charge Capture: What You Don t Know IS Killing You! Kauser Karwa MBA, RHIA, CDIP Manager McGladrey Bob Medcalf CEO Net Revenue Associates May 14, 2015 Objectives 1. Gain a broad level understanding on
More informationHCCA 13 TH ANNUAL COMPLIANCE INSTITUTE LAS VEGAS, NV APRIL 29, 2009
HCCA 13 TH ANNUAL COMPLIANCE INSTITUTE LAS VEGAS, NV APRIL 29, 2009 MEDICARE COVERAGE ANALYSIS WORKSHOP: THE HOW TO OF MEDICARE COVERAGE IN RESEARCH Suzanne LivPage, J.D. Director, Clinical Research Initiation
More informationThe ABCs of Auditing
The ABCs of Auditing Presented by: Jonnie Massey, CPC, CPC-P, CPC-I, CPMA, AHFI 1 Agenda When and how to identify records to audit Identifying red flags Resolving your audit 2 1 When Should You Start Auditing
More informationLaboratory Stewardship - The Power of Appropriate Test Utilization
Laboratory Stewardship - The Power of Appropriate Test Utilization Suzanne Carasso, MBA, MT (ASCP) Director, Business Solutions Consulting ARUP Laboratories May 23, 2018 Copyright 2016, Cardinal Health.
More informationRevenue Integrity and Chargemaster Boot Camp
*** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview The provides education on chargemaster and revenue integrity concepts in a classroom format. The program will relate
More informationInitiative Overview. Initiative kicked off in the Summer of 2016 with a series of educational workshops
Initiative kicked off in the Summer of 2016 with a series of educational workshops Initiative Overview Participating employers expressed a desire to be more active in their specialty management HBCH Board
More informationCalendar Year 2018 Medicare Hospital Outpatient Prospective Payment System Proposed Rule
Calendar Year 2018 Medicare Hospital Outpatient Prospective Payment System Proposed Rule August 2017 This document is presented for informational purposes only and is not intended to provide reimbursement
More informationDENOMINATOR: All final reports for patients, regardless of age, undergoing a CT procedure
Quality ID #363: Optimizing Patient Exposure to Ionizing Radiation: Search for Prior Computed Tomography (CT) Studies Through a Secure, Authorized, Media-Free, Shared Archive National Quality Strategy
More informationCertification in Healthcare Revenue Integrity (CHRI) Exam Outline
Certification in Healthcare Revenue Integrity (CHRI) Exam Outline I. EDUCATION 30 items (16 recall/10 application/4 analysis) a. Rules and Regulations 1. Provide expert advice in coding guidelines and
More informationWHAT'S NEW! THE HOT TOPICS
Gastroenterology Workshop Curriculum 2019 Gastroenterology Specific Coding Update. Evaluation and Management - Is your practice prepared for the Radical Changes to take place in 2021? We will update you.
More informationAdvancing the Delivery of Home Infusion Therapy curlinpump.com
Advancing the Delivery of Home Infusion Therapy curlinpump.com Innovative, multi-therapy pump designed for more precise and efficient infusions Home healthcare and drug advancements place new demands on
More information6/24/2013 AGENDA. The Art & Science of Designing a Physician Practice Audit: Unique Techniques
The Art & Science of Designing a Physician Practice Audit: Unique Techniques Lori Laubach, Health Care Partner 1 The material appearing in this presentation is for informational purposes only and is not
More informationJuly 2008 Quarterly Update for Durable Medical Equipment, Prosthetics, Orthotics, and Supplies (DMEPOS) Competitive Bidding Program
MLN Matters Number: MM6101 Revised Related Change Request (CR) #: 6101 Related CR Release Date: June 13, 2008 Effective Date: July 1, 2008 Related CR Transmittal #: R1535CP Implementation Date: July 7,
More informationClinical Policy: Tisagenlecleucel (Kymriah) Reference Number: CP.CPA.XX Effective Date: Last Review Date: Line of Business: Commercial
Clinical Policy: (Kymriah) Reference Number: CP.CPA.XX Effective Date: 09.26.17 Last Review Date: 11.17 Line of Business: Commercial Revision Log See Important Reminder at the end of this policy for important
More informationSpecialty Pharmacy 101
Specialty Pharmacy 101 The Landscape of Specialty Pharmacy Services DATE: October 27, 2011 NAME: TITLE: Clinical Pharmacist, Serve You Agenda Define specialty pharmacy Examine market trends and current
More informationOklahoma Health Care Authority
Oklahoma Health Care Authority Recovery Audit Contract Provider Outreach & Education Presentation October 22, 2013 1 Agenda Introductions HMS Overview Medicaid RAC Review Process Provider Outreach & Education
More informationCorporate Medical Policy
Corporate Medical Policy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: clinical_trial_services 3/2002 2/2018 2/2019 8/2018 Description of Procedure or Service Clinical trials are
More informationPrescription Drug Pricing. Page 1
Prescription Drug Pricing Page 1 Prescription Drugs As a Percent of Total National Health Expenditures, 1991-2014 12% 10% 8% 6% 4% 2% 0% 1991 1992 1993 1994 1995 1996 1997 1998 1999 2000 2001 2002 2003
More informationClinical Policy: Ocrelizumab (Ocrevus) Reference Number: CP.PHAR.335 Effective Date: Last Review Date: 05.18
Clinical Policy: (Ocrevus) Reference Number: CP.PHAR.335 Effective Date: 04.01.17 Last Review Date: 05.18 Line of Business: Medicaid Revision Log See Important Reminder at the end of this policy for important
More informationRMS Medical Products 24 Carpenter Road Chester, NY
RMS Medical Products 24 Carpenter Road Chester, NY 10918 1-800-624-9600 www.rmsmedpro.com info@rmsmedpro.com June 2018 Investor Presentation OTCQX: REPR Investor Relations CG Capital 1.877.889.1972 www.cg.capital
More informationJ4 Segment 3 Oklahoma and New Mexico Part B Communications Plan
J4 Segment 3 Oklahoma and New Mexico Part B Communications Plan The following is the Communications Plan for J4 Segment 3, Oklahoma and New Mexico Part B implementation. TrailBlazer Health Enterprises,
More informationMedicare Boot Camp Provider-Based Departments Version
Medicare Boot Camp Provider-Based Departments Version *** LIMITED TIME OFFER: FREE $100 AMAZON GIFT CARD! *** REGISTER TODAY! Course Overview Reimbursement for provider-based departments (PBD) and clinics
More informationNew York State Society for Clinical Social Work
Introduction to Electronic Billing New York State Society for Clinical Social Work October 15, 2011 Today s Presenters Jim Bavoso Provider Outreach & Education Agenda Introduction & Welcome Background
More informationRe: Comments on the USP Draft Medicare Model Guidelines Version 4.0
December 6, 2007 BY ELECTRONIC DELIVERY Attention: Deborah Perfetto United States Pharmacopeia Model Guidelines Submissions Department of Information Development 12601 Twinbrook Parkway Rockville, MD 20852-1790
More informationAn Integrated Solution to Your Medical Billing & Collection Needs
An Integrated Solution to Your Medical Billing & Collection Needs 12708 Riata Vista Circle Suite A126 Austin, Texas 78727 Phone: (512) 637-2002 Fax: (512) 637-2007 www.ascend-health.com Second in importance
More information2017 Cpt Icd 10 Quick Reference List Desert Rad
We have made it easy for you to find a PDF Ebooks without any digging. And by having access to our ebooks online or by storing it on your computer, you have convenient answers with 2017 cpt icd 10 quick
More informationMedical Device Replacements
Medical Device Replacements Compliance Insights for Device Warranty Credits and No Charge Devices Brenda Mickow, Revenue Compliance Officer Jesse Schafer, Explant Control Manager Mayo Clinic 2016 MFMER
More informationRE: Draft Local Coverage Determination Molecular Diagnostic Tests (MDT) (DL33599)
December 17, 2014 Elaine Jeter, MD Medical Director Palmetto GBA PO Box 100190 Columbia, SC 29202 elaine.jeter@palmettogba.com J11B.policy@PalmettoGBA.com RE: Draft Local Coverage Determination Molecular
More informationMedication Prior Authorization Form
(Orelizumab) Policy Number: 1073 Policy History Approve Date: 05/19/2017 Effective Date: 05/19/2017 Preauthorization All Plans Benefit plans vary in coverage and some plans may not provide coverage for
More informationA High-Touch Approach to Improving Patient Access. Using field support to navigate reimbursement challenges
A High-Touch Approach to Improving Patient Access Using field support to navigate reimbursement challenges For the brand and reimbursement teams who must develop commercial strategies for the biopharmaceutical
More informationContent on this page requires a newer version of Adobe Flash Player.
Content on this page requires a newer version of Adobe Flash Player. 13-1-2018 IV vesicants and pain while a vesicant will cause tissue damage if it escapes. Ciprofloxacin is not designated as a vesicant
More informationCompliance Program Accountability Scorecard
Compliance Program Accountability Scorecard Section 1 - Written Standards SCORING ITEM 1. Timely Distribution and Review of New and Revised Compliance Policies. New or revised compliance policies will
More informationThe final recommendations of the workgroups were that the CPT process should:
CPT Category III Codes: The First Ten Years (An excerpt from the May 2009 CPT Assistant) The addition of the new Category III section was announced in the February 2001 issue of the CPT Assistant. Guidelines
More informationGeriMedProfiles. Consultant Pharmacist Software
GeriMedProfiles Consultant Pharmacist Software Features GerimedProfiles TM is a comprehensive medical database for clinical pharmacists Utilizes Microsoft Access as the core database allowing the end-user
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Betaseron, Extavia) Reference Number: CP.PHAR.256 Effective Date: 08.01.16 Last Review Date: 05.18 Line of Business: Medicaid Coding Implications Revision Log See Important Reminder at
More informationEmpire BlueCross BlueShield Professional Reimbursement Policy
Subject: Frequency Editing NY Policy: 0016 Effective: 11/24/2014 04/30/2015 Coverage is subject to the terms, conditions, and limitations of an individual member s programs or products and policy criteria
More informationRe: NCA Tracking Sheet for Clinical Trial Policy (CAG-00071R)
August 9, 2006 BY ELECTRONIC DELIVERY Steve Phurrough, M.D. Coverage and Analysis Group Centers for Medicare and Medicaid Services Department of Health and Human Services Mailstop: C1-12-28 7500 Security
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Ocrevus) Reference Number: CP.PHAR.335 Effective Date: 07.01.18 Last Review Date: 05.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end of this policy
More informationMississippi Association of Medical Equipment Suppliers
Mississippi Association of Medical Equipment Suppliers Jackson, Mississippi January 26, 2016 1 Revised: April 2015. 2016 Copyright, CGS Administrators, LLC Agenda CMS Updates CGS Updates CGS Online Tools
More informationAdding Compendia for the Purposes of Making Medicare Coverage Determinations
Katherine Tillman, RN, MA Coverage and Analysis Group Centers for Medicare & Medicaid Services 7500 Security Boulevard Mail Stop S3-02-01 Baltimore, MD 21244 Re: Adding Compendia for the Purposes of Making
More informationOncology Billing Specialists
Oncology Billing Specialists ONCOLOGY Coding, Billing and Reimbursement EXPERTS When you entrust your medical billing services to RC Billing, you can rest easy knowing the details are handled to allow
More informationOctober 30, Marilyn Tavenner Administrator Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD
October 30, 2013 Marilyn Tavenner Administrator Centers for Medicare and Medicaid Services 7500 Security Boulevard Baltimore, MD 21244 8016 Re: Concerns about the Palmetto Molecular Diagnostics (MolDX)
More informationPolicies Approved by the 2018 ASHP House of Delegates
House of Delegates Policies Approved by the 2018 ASHP House of Delegates 1801 Unit Dose Packaging Availability To advocate that pharmaceutical manufacturers provide all medications used in health systems
More information